概括
人工智能 (AI) 正在通过加快数据分析,目标识别和化合物优化来彻底改变抗上药物的发现. 这种方法有望克服传统的挑战,并开发更有效的成治疗方法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 计算生物学 计算生物学
- 药物发现 药物发现 药物发现
背景情况:
- 吸毒成是一个重大的全球公共卫生挑战.
- 对于成的传统药物发现方法面临效率低下和高失败率.
- 人工智能 (AI) 提供了一种改造性的方法来增强抗上药物开发.
研究的目的:
- 审查人工智能在革新抗上药物发现中的作用.
- 探索AI如何解决传统药物开发管道中的关键缺口.
- 突出AI在推进成有效治疗策略方面的潜力.
主要方法:
- 在药物发现中对人工智能应用进行系统审查.
- 分析AI对数据收集,目标识别和化合物优化影响.
- 检查人工智能的能力,以克服传统的障碍在抗成研究.
主要成果:
- 人工智能显著提高了药物发现过程的速度和精度.
- 人工智能有助于有效处理大规模数据,这对于识别新目标至关重要.
- 人工智能简化了复合优化,可能减少开发时间表和磨损率.
结论:
- 人工智能是一个变革性的工具,有可能彻底改变抗上药物的发现.
- 通过解决传统的局限性,人工智能可以导致开发更有效的成治疗方法.
- 人工智能集成是克服挑战和推进未来抗策略的关键.
相关概念视频
Drug Abuse and Addiction: Pharmacological Phenomena
448
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
448
Drug Discovery: Overview
7.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.6K
Structure-Activity Relationships and Drug Design
677
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
677
Drug-Receptor Interaction: Agonist
2.4K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.4K
Drug Dependence
989
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
989
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
108
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
108


